Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philip Scheltens

Showing results (811-820 of 903) with videos related to

Pageof 91
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2025
Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's diseaseEleonora M Vromen, Senne B Lageman, Johan Gobom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2019
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrumIsabelle Bos, Stephanie Vos, Frans Verhey, et al.
Neurology|February 20, 2024
Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer DiseaseMerle Hönig, Daniele Altomare, Camilla Caprioglio, et al.
Neurology|July 18, 2020
Multitracer model for staging cortical amyloid deposition using PET imagingLyduine E Collij, Fiona Heeman, Gemma Salvadó, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
EJNMMI Research|January 24, 2022
Validation and test-retest repeatability performance of parametric methods for [<sup>11</sup>C]UCB-J PETHayel Tuncel, Ronald Boellaard, Emma M Coomans, et al.
Brain : a Journal of Neurology|July 5, 2015
The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological featuresRik Ossenkoppele, Yolande A L Pijnenburg, David C Perry, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 11, 2019
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD studyAlberto Lleó, Daniel Alcolea, Pablo Martínez-Lage, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 4, 2024
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History StudyAriane Bollack, Lyduine E Collij, David Vállez García, et al.
JAMA Neurology|May 8, 2023
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical TrialDaniele Altomare, Frederik Barkhof, Camilla Caprioglio, et al.
Pageof 91

Showing results (811-820 of 903) with videos related to

Sort By:
Pageof 91
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|October 14, 2025
Cerebrospinal fluid proteomic associations of APOE genotypes reveal distinct protective and risk mechanisms for Alzheimer's diseaseEleonora M Vromen, Senne B Lageman, Johan Gobom, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 12, 2019
Cerebrospinal fluid biomarkers of neurodegeneration, synaptic integrity, and astroglial activation across the clinical Alzheimer's disease spectrumIsabelle Bos, Stephanie Vos, Frans Verhey, et al.
Neurology|February 20, 2024
Association Between Years of Education and Amyloid Burden in Patients With Subjective Cognitive Decline, MCI, and Alzheimer DiseaseMerle Hönig, Daniele Altomare, Camilla Caprioglio, et al.
Neurology|July 18, 2020
Multitracer model for staging cortical amyloid deposition using PET imagingLyduine E Collij, Fiona Heeman, Gemma Salvadó, et al.
Medrxiv : the Preprint Server for Health Sciences|November 11, 2020
Cerebrospinal fluid total tau levels indicate aberrant neuronal plasticity in Alzheimer's diseasePieter Jelle Visser, Lianne M Reus, Johan Gobom, et al.
EJNMMI Research|January 24, 2022
Validation and test-retest repeatability performance of parametric methods for [<sup>11</sup>C]UCB-J PETHayel Tuncel, Ronald Boellaard, Emma M Coomans, et al.
Brain : a Journal of Neurology|July 5, 2015
The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological featuresRik Ossenkoppele, Yolande A L Pijnenburg, David C Perry, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 11, 2019
Longitudinal cerebrospinal fluid biomarker trajectories along the Alzheimer's disease continuum in the BIOMARKAPD studyAlberto Lleó, Daniel Alcolea, Pablo Martínez-Lage, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 4, 2024
Investigating reliable amyloid accumulation in Centiloids: Results from the AMYPAD Prognostic and Natural History StudyAriane Bollack, Lyduine E Collij, David Vállez García, et al.
JAMA Neurology|May 8, 2023
Clinical Effect of Early vs Late Amyloid Positron Emission Tomography in Memory Clinic Patients: The AMYPAD-DPMS Randomized Clinical TrialDaniele Altomare, Frederik Barkhof, Camilla Caprioglio, et al.
Pageof 91